Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
The case centers on allegations brought by Arbutus Biopharma and Genevant Sciences, two biotechnology firms that claim Moderna’s highly successful COVID-19 vaccine, Spikevax, infringes on patents related to lipid nano...
Share This Article
Ready-to-post copy includes the article link.
Moderna Fights to Keep Vaccine IP Case Narrow Amid Ongoing Legal Battle The case centers on allegations brought by Arbutus Biopharma and Genevant Sciences, two biotechnology firms that claim Moderna’s highly successful COVID-19 vaccine, Spikevax, infringes on patents related to lipid nano... Read the full IIPLA article: https://iipla.org/news/moderna-defend-covid-patent-suit